IBDEI1X9 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,30697,1,3,0)
;;=3^Diabetes Type 1 w/ Diabetic Neuropathy
;;^UTILITY(U,$J,358.3,30697,1,4,0)
;;=4^E10.40
;;^UTILITY(U,$J,358.3,30697,2)
;;=^5002604
;;^UTILITY(U,$J,358.3,30698,0)
;;=E10.22^^123^1582^2
;;^UTILITY(U,$J,358.3,30698,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30698,1,3,0)
;;=3^Diabetes Type 1 w/ Diabetic CKD
;;^UTILITY(U,$J,358.3,30698,1,4,0)
;;=4^E10.22
;;^UTILITY(U,$J,358.3,30698,2)
;;=^5002590
;;^UTILITY(U,$J,358.3,30699,0)
;;=E10.9^^123^1582^7
;;^UTILITY(U,$J,358.3,30699,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30699,1,3,0)
;;=3^Diabetes Type 1 w/o Complications
;;^UTILITY(U,$J,358.3,30699,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,30699,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,30700,0)
;;=E11.22^^123^1582^8
;;^UTILITY(U,$J,358.3,30700,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30700,1,3,0)
;;=3^Diabetes Type 2 w/ Diabetic CKD
;;^UTILITY(U,$J,358.3,30700,1,4,0)
;;=4^E11.22
;;^UTILITY(U,$J,358.3,30700,2)
;;=^5002630
;;^UTILITY(U,$J,358.3,30701,0)
;;=E11.9^^123^1582^12
;;^UTILITY(U,$J,358.3,30701,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30701,1,3,0)
;;=3^Diabetes Type 2 w/o Complications
;;^UTILITY(U,$J,358.3,30701,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,30701,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,30702,0)
;;=E13.22^^123^1582^1
;;^UTILITY(U,$J,358.3,30702,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30702,1,3,0)
;;=3^DM w/ Diabetic CKD,Other
;;^UTILITY(U,$J,358.3,30702,1,4,0)
;;=4^E13.22
;;^UTILITY(U,$J,358.3,30702,2)
;;=^5002671
;;^UTILITY(U,$J,358.3,30703,0)
;;=E83.30^^123^1583^26
;;^UTILITY(U,$J,358.3,30703,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30703,1,3,0)
;;=3^Phosphorus Metabolism Disorder,Unspec
;;^UTILITY(U,$J,358.3,30703,1,4,0)
;;=4^E83.30
;;^UTILITY(U,$J,358.3,30703,2)
;;=^5002997
;;^UTILITY(U,$J,358.3,30704,0)
;;=E83.31^^123^1583^9
;;^UTILITY(U,$J,358.3,30704,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30704,1,3,0)
;;=3^Familial Hypophosphatemia
;;^UTILITY(U,$J,358.3,30704,1,4,0)
;;=4^E83.31
;;^UTILITY(U,$J,358.3,30704,2)
;;=^5002998
;;^UTILITY(U,$J,358.3,30705,0)
;;=E83.51^^123^1583^19
;;^UTILITY(U,$J,358.3,30705,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30705,1,3,0)
;;=3^Hypocalcemia
;;^UTILITY(U,$J,358.3,30705,1,4,0)
;;=4^E83.51
;;^UTILITY(U,$J,358.3,30705,2)
;;=^60542
;;^UTILITY(U,$J,358.3,30706,0)
;;=E83.52^^123^1583^13
;;^UTILITY(U,$J,358.3,30706,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30706,1,3,0)
;;=3^Hypercalcemia
;;^UTILITY(U,$J,358.3,30706,1,4,0)
;;=4^E83.52
;;^UTILITY(U,$J,358.3,30706,2)
;;=^59932
;;^UTILITY(U,$J,358.3,30707,0)
;;=E87.0^^123^1583^16
;;^UTILITY(U,$J,358.3,30707,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30707,1,3,0)
;;=3^Hyperosmolality and Hypernatremia
;;^UTILITY(U,$J,358.3,30707,1,4,0)
;;=4^E87.0
;;^UTILITY(U,$J,358.3,30707,2)
;;=^5003018
;;^UTILITY(U,$J,358.3,30708,0)
;;=E87.1^^123^1583^18
;;^UTILITY(U,$J,358.3,30708,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30708,1,3,0)
;;=3^Hypo-osmolality and Hyponatremia
;;^UTILITY(U,$J,358.3,30708,1,4,0)
;;=4^E87.1
;;^UTILITY(U,$J,358.3,30708,2)
;;=^5003019
;;^UTILITY(U,$J,358.3,30709,0)
;;=E87.2^^123^1583^1
;;^UTILITY(U,$J,358.3,30709,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30709,1,3,0)
;;=3^Acidosis
;;^UTILITY(U,$J,358.3,30709,1,4,0)
;;=4^E87.2
;;^UTILITY(U,$J,358.3,30709,2)
;;=^5003020
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1X9 3789 printed Apr 09, 2024@21:07:23 Page 2
IBDEI1X9 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,30697,1,3,0)
+2 ;;=3^Diabetes Type 1 w/ Diabetic Neuropathy
+3 ;;^UTILITY(U,$J,358.3,30697,1,4,0)
+4 ;;=4^E10.40
+5 ;;^UTILITY(U,$J,358.3,30697,2)
+6 ;;=^5002604
+7 ;;^UTILITY(U,$J,358.3,30698,0)
+8 ;;=E10.22^^123^1582^2
+9 ;;^UTILITY(U,$J,358.3,30698,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,30698,1,3,0)
+12 ;;=3^Diabetes Type 1 w/ Diabetic CKD
+13 ;;^UTILITY(U,$J,358.3,30698,1,4,0)
+14 ;;=4^E10.22
+15 ;;^UTILITY(U,$J,358.3,30698,2)
+16 ;;=^5002590
+17 ;;^UTILITY(U,$J,358.3,30699,0)
+18 ;;=E10.9^^123^1582^7
+19 ;;^UTILITY(U,$J,358.3,30699,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,30699,1,3,0)
+22 ;;=3^Diabetes Type 1 w/o Complications
+23 ;;^UTILITY(U,$J,358.3,30699,1,4,0)
+24 ;;=4^E10.9
+25 ;;^UTILITY(U,$J,358.3,30699,2)
+26 ;;=^5002626
+27 ;;^UTILITY(U,$J,358.3,30700,0)
+28 ;;=E11.22^^123^1582^8
+29 ;;^UTILITY(U,$J,358.3,30700,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,30700,1,3,0)
+32 ;;=3^Diabetes Type 2 w/ Diabetic CKD
+33 ;;^UTILITY(U,$J,358.3,30700,1,4,0)
+34 ;;=4^E11.22
+35 ;;^UTILITY(U,$J,358.3,30700,2)
+36 ;;=^5002630
+37 ;;^UTILITY(U,$J,358.3,30701,0)
+38 ;;=E11.9^^123^1582^12
+39 ;;^UTILITY(U,$J,358.3,30701,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,30701,1,3,0)
+42 ;;=3^Diabetes Type 2 w/o Complications
+43 ;;^UTILITY(U,$J,358.3,30701,1,4,0)
+44 ;;=4^E11.9
+45 ;;^UTILITY(U,$J,358.3,30701,2)
+46 ;;=^5002666
+47 ;;^UTILITY(U,$J,358.3,30702,0)
+48 ;;=E13.22^^123^1582^1
+49 ;;^UTILITY(U,$J,358.3,30702,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,30702,1,3,0)
+52 ;;=3^DM w/ Diabetic CKD,Other
+53 ;;^UTILITY(U,$J,358.3,30702,1,4,0)
+54 ;;=4^E13.22
+55 ;;^UTILITY(U,$J,358.3,30702,2)
+56 ;;=^5002671
+57 ;;^UTILITY(U,$J,358.3,30703,0)
+58 ;;=E83.30^^123^1583^26
+59 ;;^UTILITY(U,$J,358.3,30703,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,30703,1,3,0)
+62 ;;=3^Phosphorus Metabolism Disorder,Unspec
+63 ;;^UTILITY(U,$J,358.3,30703,1,4,0)
+64 ;;=4^E83.30
+65 ;;^UTILITY(U,$J,358.3,30703,2)
+66 ;;=^5002997
+67 ;;^UTILITY(U,$J,358.3,30704,0)
+68 ;;=E83.31^^123^1583^9
+69 ;;^UTILITY(U,$J,358.3,30704,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,30704,1,3,0)
+72 ;;=3^Familial Hypophosphatemia
+73 ;;^UTILITY(U,$J,358.3,30704,1,4,0)
+74 ;;=4^E83.31
+75 ;;^UTILITY(U,$J,358.3,30704,2)
+76 ;;=^5002998
+77 ;;^UTILITY(U,$J,358.3,30705,0)
+78 ;;=E83.51^^123^1583^19
+79 ;;^UTILITY(U,$J,358.3,30705,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,30705,1,3,0)
+82 ;;=3^Hypocalcemia
+83 ;;^UTILITY(U,$J,358.3,30705,1,4,0)
+84 ;;=4^E83.51
+85 ;;^UTILITY(U,$J,358.3,30705,2)
+86 ;;=^60542
+87 ;;^UTILITY(U,$J,358.3,30706,0)
+88 ;;=E83.52^^123^1583^13
+89 ;;^UTILITY(U,$J,358.3,30706,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,30706,1,3,0)
+92 ;;=3^Hypercalcemia
+93 ;;^UTILITY(U,$J,358.3,30706,1,4,0)
+94 ;;=4^E83.52
+95 ;;^UTILITY(U,$J,358.3,30706,2)
+96 ;;=^59932
+97 ;;^UTILITY(U,$J,358.3,30707,0)
+98 ;;=E87.0^^123^1583^16
+99 ;;^UTILITY(U,$J,358.3,30707,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,30707,1,3,0)
+102 ;;=3^Hyperosmolality and Hypernatremia
+103 ;;^UTILITY(U,$J,358.3,30707,1,4,0)
+104 ;;=4^E87.0
+105 ;;^UTILITY(U,$J,358.3,30707,2)
+106 ;;=^5003018
+107 ;;^UTILITY(U,$J,358.3,30708,0)
+108 ;;=E87.1^^123^1583^18
+109 ;;^UTILITY(U,$J,358.3,30708,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,30708,1,3,0)
+112 ;;=3^Hypo-osmolality and Hyponatremia
+113 ;;^UTILITY(U,$J,358.3,30708,1,4,0)
+114 ;;=4^E87.1
+115 ;;^UTILITY(U,$J,358.3,30708,2)
+116 ;;=^5003019
+117 ;;^UTILITY(U,$J,358.3,30709,0)
+118 ;;=E87.2^^123^1583^1
+119 ;;^UTILITY(U,$J,358.3,30709,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,30709,1,3,0)
+122 ;;=3^Acidosis
+123 ;;^UTILITY(U,$J,358.3,30709,1,4,0)
+124 ;;=4^E87.2
+125 ;;^UTILITY(U,$J,358.3,30709,2)
+126 ;;=^5003020
